JANSSEN CILAG S.A secures contract for Antineoplastic agents - Acquisition of the pharmaceutical specialty CARVYKTY, 3.2 x 10e6-1 x 10e8 cells dispersion for perfusion (Ciltacabtagen Autoleucel), destined for the Pharmacy Service of the Ramon y Cajal University Hospital

Spain, Dec. 8 -- Spain based JANSSEN CILAG S.A has secured contract from HOSPITAL UNIVERSITARIO RAMON Y CAJAL for Antineoplastic agents - Acquisition of the pharmaceutical specialty CARVYKTY, 3.2 x 10e6-1 x 10e8 cells dispersion for perfusion (Ciltacabtagen Autoleucel), destined for the Pharmacy Service of the Ramon y Cajal University Hospital. The value of the contract is worth 282399997 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....